| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |